- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 207.49M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 217.65M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 216.55M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $88.83M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $44.81M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $264.49M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $82.34M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $66.12M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $51.42M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $0 |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $229.64M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $634.09M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $524.75M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.63B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.51B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $688.67M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $618.36M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.52B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.78B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.67B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.29B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $5.95B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $6.09B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.52 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.28 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.52 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.29 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $38.48M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $23.89M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$106.45M |
| Net Income | Q1 2026 · Mar 31, 2025 | $58.78M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $300.38M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $106.78M |